Primary Menu

Skip to content
Lycera
  • About Us
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Expanded Access
  • Programs
    • LYC-55716
    • ATPase Modulators
    • New IO Targets
  • Pipeline
  • Investors
    • Investors
    • Investor FAQ’s
    • Contact Us
  • News & Events
    • Press Releases
    • Lycera in the News
  • Careers
    • Contact Us

Digestive Disease Week 2014 (Poster)

  Aug 26, 2014    Luigi Franchi, Kelan A. Hlavaty, Ivan Monteleone, Rodney Morgan, Kelli Porzondek, Brian Sanchez, Charles Lesch, Mark A. Spahr, Corrin Hepburn, Anthony W. Opipari, Giovanni Monteleone, Gary Glick, Laura Carter, Peter D. Higgins

F1F0-ATPase Modulation Is Efficacious in Models in IBD and Induces Apoptosis of Human CCR9+ Gut-Tropic T-cells

Footer Menu

  • Contact Us

Social Media Menu

  • LinkedIn
© 2021 Lycera - website by ZURNET